TY - JOUR 
AU - Vargas M.
AU - Villarraga E.
PY - 2017
UR - http://hdl.handle.net/10818/37545
AB - A study with the aim to compare the bioavailability of two 400 mg imatinib formulations, test product Zeite® from
Laboratorio Synthesis S.A.S., Colombia, and reference product Glivec® from Novartis Pharma, and determine if
bioequivalence can be...
LA - eng
PB - Journal of Bioequivalence & Bioavailability
KW - Bioequivalence
KW - Imatinib
KW - Oncologic
KW - Pharmacokinetics
TI - Bioequivalence Study of Imatinib Formulations that Contain 400 mg in Healthy Colombians
DO - 10.4172/jbb.1000349
ER -